A meta-analysis of 10 RCTs shows medical cannabis can reduce dementia-related agitation—a behavioral symptom that devastates both patients and caregivers. Cannabinoids showed effectiveness comparable to antipsychotics but with a safer profile, especially at doses above 10 mg THC-equivalent. This evidence offers caregivers and physicians a potential alternative when antipsychotic medications carry too much risk
CBD Gummies for Dementia on Shark Tank: Separating Fact from Hype
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DementiaCbdMarketing ClaimsNeurologyConsumer Products Why This Matters Television marketing of CBD products for dementia exploits...
CBD Gummies and Alzheimer’s: What the Evidence Shows for Cognitive and Behavioral Support
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Alzheimer'SDementiaCbdNeuroprotectionBehavioral Symptoms Why This MattersAs Alzheimer's disease affects over 6 million Americans with limited...
CBD Gummies for Dementia: What the Evidence Shows and How to Evaluate Them
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DementiaCbdGeriatricsDrug InteractionsEvidence-Based Medicine Why This MattersDementia affects over 55 million people worldwide, with limited...
Could cannabis help dementia patients with symptoms like agitation, memory loss, and … – Facebook
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DementiaBehavioral SymptomsGeriatricsAgitationNeuroinflammation Why This MattersDementia affects over 55 million people worldwide, with limited therapeutic...
Cannabis edibles in dementia care: What families should know – Hawaii News Now
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DementiaGeriatricsEdiblesSafetyFamily Care Why This MattersDementia affects over 6 million Americans, and families increasingly ask...
Cannabis edibles in dementia care: What families should know – AZ Family
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DementiaGeriatricsEdiblesBehavioral SymptomsFamily Medicine Why This MattersDementia patients are increasingly being given cannabis edibles by...
Cannabis and Dementia Risk: The Truth Behind the Scary Headline
A new study links cannabis-related ER visits to higher dementia risk—but the findings are more about hospital crises than cannabinoids. It’s not about everyday users, and it doesn’t prove causation. Here’s what this paper really tells us—and what it doesn’t.